Annual Drug Patent Expirations for NASCOBAL
Nascobal is a drug marketed by Par Pharm and Endo Pharms Inc and is included in two NDAs. It is available from one supplier. There are six patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for NASCOBAL.
The generic ingredient in NASCOBAL is cyanocobalamin. One supplier is listed for this compound. Additional details are available on the cyanocobalamin profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
